The beauty and aesthetics industry has experienced wave after wave of technological innovation — in fact, according to Vantage market research, sales for smart devices in the beauty business is estimated to reach US$144.2 billion by 2028, with a yearly growth rate of an outstanding 18.8%. In line with this demand, aesthetic and medical solutions leader BTL Aesthetics is introducing its newest technology, EXION.
The EXION, a cutting-edge 4-in-1 device designed to address skin, face, body, and intimate health concerns, is revolutionising the aesthetic landscape. It offers a leap in body contouring technology with results that speak volumes — primarily a 224% increase in hyaluronic acid naturally without needles, allowing one’s skin to stretch and flex naturally while reducing skin wrinkles and lines.
The launch took place at Hyatt Place Bukit Jalil, where BTL Aesthetics was able to showcase how the EXION allows medical professionals to target multiple body areas and aesthetic concerns with impressive patient comfort and minimal to no downtime, using top-of-the-line subdermal remodelling capabilities. Notably, the EXION showcases a variety of unprecedented outcomes, including a 85% improvement in skin laxity, and a remarkable 22% reduction in fat.
“We are thrilled that the EXION is now available in Malaysia for medical professionals seeking an advanced solution to meet the varied aesthetic and medical needs of their patients,” says Rebecca Arthur, Medical Device Country Manager of BTL Aesthetics. “Ideally, our goal is to ensure that Malaysians with aesthetic concerns will no longer have to push through pain or discomfort only to be disappointed by unsatisfactory results — the EXION presents a groundbreaking solution for both comfort and efficacy.”
Also read: #InvestInWomen: Addressing Challenges and Championing Inclusion in the Digital Space
The EXION is engineered to treat over 23 different areas, from facial zones like the periorbital area and forehead to larger body regions, including the arms, abdomen, thighs, and buttocks. Its utility and effectiveness is supported by both extensive clinical trials and medical professionals, including Dr Nurul Ain Abdullah, Founder & Medical Director of Alainn Clinic; Dr Lynda Quah, Managing Director & Aesthetic Doctor of Revival Medical Clinic; Dr Valynne Ng, Clinical Director of Clinic RX; and Dr Joann Law, Founder & Medical Director of Mira Clinic.
In order to tackle all layers of the skin in multiple areas, the EXION uses four advanced applicators which include: FRACTIONAL RF, which uses microneedling technology for skin tightening and skin texture enhancement; FACE, which stimulates the body’s natural production of hyaluronic acid without needles; BODY, which effectively addresses lax skin and localised fat deposits; and EMFEMME 360, which offers a quick, discomfort-free path for women to reclaim their intimate health and aesthetic desires.
This groundbreaking technology is driven by Advanced Artificial Intelligence (AI), representing a significant advancement in the aesthetic industry. Through the use of microneedling technology, monopolar RF technology, and a patented combination of simultaneous RF and targeted ultrasound technology, the EXION ultimately provides optimum results that are minimally invasive.
Ultimately, with the EXION, customers can enjoy the benefits of advanced aesthetic and medical solutions without compromising comfort. BTL Aesthetics’ core mission is to use its 30 years of continuous innovation to keep finding comfortable, safe, and efficient methods of carrying out medical aesthetic treatments.
For more information, visit https://btlaesthetics.com/en/for-providers/exion-providers.
Legal Disclaimer: The Editor provides this news content "as is," without any warranty of any kind. We disclaim all responsibility and liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. For any complaints or copyright concerns regarding this article, please contact the author mentioned above.
